Hemant K. Misra

PEGylated Carboxyhemoglobin Bovine (SANGUINATE): Results of a Phase I Clinical Trial

Hemant K. Misra, Jason D. Lickliter, Friedericke Kazo et al. · Artificial Organs · 2014 · 71 citations

Medicine, Pharmacology, Pharmacotherapy +13

A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia

Hemant K. Misra, James Bainbridge, John Berryman et al. · Revista Brasileira de Hematologia e Hemoterapia · 2016 · 55 citations · Full text

Medicine, Hematology, Pharmacology +12

Synthesis of 131I, 125I, 123I and 82Br labelled 5-halo-1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)uracils

Hemant K. Misra, Edward E. Knaus, Leonard I. Wiebe et al. · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · 1986 · 19 citations

Natural Sciences, Chemistry, Organic Chemistry +1

SANGUINATE™ (PEGylated Carboxyhemoglobin Bovine) Improves Cerebral Blood Flow to Vulnerable Brain Regions at Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

Rajat Dhar, Hemant K. Misra, Michael N. Diringer · Neurocritical Care · 2017 · 19 citations

Medicine, Neuroscience, Neurosurgery +16

A phase Ib, open‐label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of <scp>SANGUINATE</scp> infusion in patients with end‐stage renal disease

Bassam G. Abu Jawdeh, E. Steve Woodle, Abbie D. Leino et al. · Clinical Transplantation · 2017 · 18 citations

Medicine, Pharmacokinetics, Pharmacology +16